Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord Stimulation in Treating Patients With Chronic Pelvic Pain
Launched by STANFORD UNIVERSITY · Apr 17, 2024
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment for people suffering from chronic pelvic pain, which is pain that lasts for more than six months and hasn’t improved with other medical treatments. The treatment being evaluated is called closed-loop spinal cord stimulation. This method uses a device that sends electrical signals to the spinal cord to help relieve pain. Unlike traditional spinal cord stimulation, this new approach automatically adjusts the energy it delivers based on real-time feedback, potentially making it more effective and safe for patients.
To be eligible for this trial, participants need to be adults aged 18 or older who have been experiencing pelvic pain for at least six months without relief from standard medical options. However, people with certain serious health conditions, specific causes of pelvic pain that can be treated differently, or significant psychological issues may not qualify. If you participate in this trial, you can expect to undergo the closed-loop spinal cord stimulation treatment and be monitored for its effectiveness and safety. This trial is currently not recruiting participants yet, but it aims to provide valuable insights into a promising new approach to managing chronic pelvic pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The investigators will include all adult patients (18 or older) with pelvic pain more than 6 months that has not responded to conservative medical management
- Exclusion Criteria:
- • Major untreated medical comorbidities (uncontrolled diabetes mellitus, severe obesity, uncontrolled cardiopulmonary disease, etc.)
- • Secondary causes of pelvic pain that can be treated with appropriate medical or surgical interventions
- • Major untreated psychological comorbidities
- • Anatomical challeneges to place spinal cord stimulator
- • Ongoing legal or disability claims
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported